Rabeprazole

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.11 [0.72, 1.73]21%2 studies108,27513,456not evaluable ROB-
Major congenital malformations1.11 [0.72, 1.73]21%2 studies108,27513,456not evaluable ROB-
4 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
1 non statistically significant endpoints reported in only one study